Methods of treating based on site-specific tau phosphorylation
US11085935B2 · kind B2 · utility
3Cited by
2References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 9, 2020 |
| Grant date | Aug 10, 2021 |
| Priority date | — |
| Expiry date | Sep 9, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2440/14
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present disclosure provides methods to quantify tau phosphorylation at specific amino acid residues to predict time to onset of mild cognitive impairment due to Alzheimer's disease, stage Alzheimer's disease, guide treatment decisions, select subjects for clinical trials, and evaluate the clinical efficacy of certain therapeutic interventions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.